Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05005221 · ClinicalTrials.gov registry record · NA
Home-based Therapeutic Drug Monitoring in Kidney Transplantation
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05005221 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 41 participants.
The verdict
NCT05005221, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This is a randomized clinical trial to assess an intervention to facilitate patient self-collection of dried blood samples at home for therapeutic drug monitoring of tacrolimus and mycophenolate in kidney transplant recipients. In this study, text messages will be sent to mobile devices to remind kidney transplant recipients to perform therapeutic drug monitoring at home using a special lancet device to collect blood samples from the upper arm. The primary objective is to evaluate if more intensive, bidirectional text messages improve the quality of sample collection.
Interventions
- BEHAVIORAL Automated text messages
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2022-11-08 |
| Est. Completion | 2024-05-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05005221
The ClinicalTrials.gov registry entry for NCT05005221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Automated text messages is the first listed.
NCT05005221 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05005221 about?
NCT05005221 is a clinical study titled "Home-based Therapeutic Drug Monitoring in Kidney Transplantation". This is a randomized clinical trial to assess an intervention to facilitate patient self-collection of dried blood samples at home for therapeutic drug monitoring of tacrolimus and mycophenolate in kidney transplant recipients. In this study, text messages will be sent to mobile devices to remind k...
What is the current status of trial NCT05005221?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2022-11-08. Estimated completion is 2024-05-08.
What interventions are being tested in trial NCT05005221?
The interventions under investigation include: Automated text messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT05005221?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.